Abcellera Biologics Stock Math Operators Price Series Division

ABCL Stock  USD 2.72  0.04  1.45%   
Abcellera Biologics math operators tool provides the execution environment for running the Price Series Division operator and other technical functions against Abcellera Biologics. Abcellera Biologics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of math operators indicators. As with most other technical indicators, the Price Series Division operator function is designed to identify and follow existing trends and Virax Biolabs Group. Math Operators module provides interface to determine different price movement patterns of similar pairs of equity instruments such as Virax Biolabs Group and Abcellera Biologics.

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Abcellera Biologics Price Series Division is a division of Abcellera Biologics price series and its benchmark/peer.

Abcellera Biologics Technical Analysis Modules

Most technical analysis of Abcellera Biologics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Abcellera from various momentum indicators to cycle indicators. When you analyze Abcellera charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Abcellera Biologics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Abcellera Biologics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Abcellera Biologics based on widely used predictive technical indicators. In general, we focus on analyzing Abcellera Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Abcellera Biologics's daily price indicators and compare them against related drivers, such as math operators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Abcellera Biologics's intrinsic value. In addition to deriving basic predictive indicators for Abcellera Biologics, we also check how macroeconomic factors affect Abcellera Biologics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding156.2129.02618.0648.9
PTB Ratio3.842.341.431.36
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Abcellera Biologics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.142.736.48
Details
Intrinsic
Valuation
LowRealHigh
2.457.9111.66
Details
Naive
Forecast
LowNextHigh
0.052.686.43
Details
9 Analysts
Consensus
LowTargetHigh
21.7323.8826.51
Details

Learn to be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run FinTech Suite Now

   

FinTech Suite

Use AI to screen and filter profitable investment opportunities
All  Next Launch Module

Abcellera Biologics pair trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abcellera Biologics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera Biologics will appreciate offsetting losses from the drop in the long position's value.

Abcellera Biologics Pair Trading

Abcellera Biologics Pair Trading Analysis

The ability to find closely correlated positions to Abcellera Biologics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abcellera Biologics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abcellera Biologics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abcellera Biologics to buy it.
The correlation of Abcellera Biologics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abcellera Biologics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abcellera Biologics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abcellera Biologics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Abcellera Biologics is a strong investment it is important to analyze Abcellera Biologics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Abcellera Biologics' future performance. For an informed investment choice regarding Abcellera Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abcellera Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abcellera Biologics. If investors know Abcellera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abcellera Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.459
Earnings Share
(0.61)
Revenue Per Share
0.112
Quarterly Revenue Growth
(0.01)
Return On Assets
(0.13)
The market value of Abcellera Biologics is measured differently than its book value, which is the value of Abcellera that is recorded on the company's balance sheet. Investors also form their own opinion of Abcellera Biologics' value that differs from its market value or its book value, called intrinsic value, which is Abcellera Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abcellera Biologics' market value can be influenced by many factors that don't directly affect Abcellera Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abcellera Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abcellera Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abcellera Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.